Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, EspañaInstitut d'Investigacions Biomèdiques August Pi i Sunyer-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2024
-
Evidence and choice: The BCLC vision for tailoring clinical decision-making
Journal of Hepatology
2023
-
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma (Frontiers in Pharmacology, (2023), 14, (1124214), 10.3389/fphar.2023.1124214)
Frontiers in Pharmacology
-
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
Frontiers in Pharmacology, Vol. 14
2022
-
Liver diseases: a sanitary and social challenge for Europe in the XXI Century. Results of EASL-Lancet Comission
Medicina Clinica
-
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
The Lancet, Vol. 399, Núm. 10319, pp. 61-116
2021
-
Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage
Hepatology, Vol. 74, Núm. 5, pp. 2791-2807